EPIC SCIENCES

In News

Study Failure Spotlights Challenges for ctDNA Strategies in Breast Cancer Drug Trials - GenomeWeb

GenomeWeb - Dec 16, 2024

Epic Sciences Raises $24M in Series G Financing to Continue Funding Commercialization of DefineMBC - Business Wire

Business Wire - Apr 14, 2023

Disease Progression Diagnostics Company Epic Sciences Raises $24 Million - Pulse 2.0

Pulse 2.0 - Apr 19, 2023

Epic Sciences Launches New Corporate Branding and Website - PR Newswire

PR Newswire - May 13, 2019

Lloyd Sanders Named New CEO of Epic Sciences - Inside Precision Medicine

Inside Precision Medicine - Mar 26, 2019

New Life Sciences Program Will Unify Clinical Research with Care Delivery - Epic Systems

Epic Systems - Sep 19, 2022

From Computer Science to Classics, an Epic Journey - Dartmouth

Dartmouth - Jul 09, 2024

Epic Science - American Scientist

American Scientist - Feb 12, 2018

Circulating Tumor Cells Market to Lead by 13.64% of CAGR by 2033 - BioSpace

BioSpace - Jul 11, 2024

How liquid biopsies are transforming precision cancer care - Nature

Nature - Apr 20, 2021

Summary of the Ninth DSCOVR EPIC and NISTAR Science Team Meeting - NASA Science (.gov)

NASA Science (.gov) - Jun 14, 2024

Greater FDA Oversight of Laboratory-Developed Tests: A Needed Change? - Cancer Therapy Advisor

Cancer Therapy Advisor - May 17, 2024

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.